Hematology NewsNovel JAK1 inhibitor shows promise for myeloid malignanciesJanuary 18, 2018Multiple MyelomaMyelodysplastic SyndromeAML
Hematology NewsFDA approves injection treatment for low-risk APLJanuary 17, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesFDA expands approval for arsenic trioxideJanuary 16, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesEMA recommends orphan designation for pracinostatJanuary 12, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesSurvival differences among AYAs with blood cancersJanuary 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Hematology TimesMarine animals aid development of cytotoxicity assayJanuary 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLCMLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesTeam finds way to target MYB in AMLJanuary 9, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsDNA sequencing could help identify relapse risk in treated AMLJanuary 4, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesCX-01 receives orphan designation for AMLJanuary 4, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsSorafenib plus chemo prolongs event-free survival in AMLJanuary 3, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesFDA lifts hold on trial of SEL24 in AMLJanuary 3, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesIron chelating agent could enhance chemo in AMLDecember 28, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesFDA grants orphan designation to drug for AMLDecember 27, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology NewsVIDEO: Joint FDA-ASH session highlights new AML drugsDecember 14, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsAzacitidine maintenance improves PFS in older AML patientsDecember 11, 2017AMLLeukemia, Myelodysplasia, Transplantation
